Search Medical Condition
Please enter condition
Please choose location from dropdown
 

D, South Africa Clinical Trials

A listing of D, South Africa clinical trials actively recruiting patients volunteers.

RESULTS

Found (2864) clinical trials

Outpatient study designed to test a new investigational medication in adults 50 years and older with insomnia. Compensation is $1450. To qualify, you must be 50 years and older. Length of study: 4-6 weeks Overnight visits: 5 Total number of outpatient visits: 6 For more information,

Phase N/A

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia. To qualify, you must be: 18 years and older Length of study: 6 weeks Overnight visits: 10 Total number of outpatient visits: 1 For more information,

Phase N/A

This is a randomized, double-blind, placebo-controlled, multicenter phase III study. The study population will consist of approximately 1300 subjects with metastatic hormone sensitive prostate cancer (mHSPC), who will be randomized (1:1 ratio) to receive 600 mg (2 x 300 mg tablets) of darolutamide (ODM-201)/placebo twice daily with food, equivalent to ...

Phase

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Eligibility Criteria: Each child must have a responsible trained adult with knowledge of the conduct of the study and must be available to supervise migraine ...

Phase

The purpose of the study is to examine the impact of nasal irrigation (Neti-pot) and/or smell training for patients with hyposmia (reduced ability to smell) or anosmia (no ability to smell). Phase 1 of the research study is 32 days with 2 study visits that will last 2 hours each. ...

Must be Female, 18 to 80 years of age Undergone spontaneous medically induced, or surgical menopause prior to start of study

Phase N/A

Do you experience migraines? Rapid Medical Research is looking for volunteers to participate in a clinical research study for migraine headaches. Eligibility Criteria: To pre-qualify, you must: Be between the ages of 18 to 75 years of age and Have had at least 1 year of migraine, with or without ...

Phase

This is an adaptive, Phase II/III study in 2 parts (i.e. Part 1 (dose ranging) and Part 2 (Hypothesis testing)). NaBen® is granted Breakthrough Therapy Designation by US FDA as treatment for refractory schizophrenia.

Phase N/A